Skip to main content
Premium Trial:

Request an Annual Quote

Roche Extends Takeover Offer for Illumina at Same Price

NEW YORK (GenomeWeb News) – Roche has extended its $5.7 billion hostile takeover bid for Illumina for another month at the same price, the company said today.

Roche's offer for Illumina, at $44.50 per share, was set to expire on March 23. The company has now extended it to April 20 at 6 pm EDT, keeping all terms and conditions the same. This is the second time Roche has prolonged the offer, which originally expired Feb. 24.

The offer will now be valid until after Illumina's annual shareholder meeting on April 18. During that meeting, shareholders will elect four members of Illumina's board of directors and vote on a proposal by Roche to expand the board by two members. Roche hopes to fill all open board positions with its own candidates.

Roche said that 144,208 shares had been tendered as of March 23, including 102 shares guaranteed to be delivered within the next three Nasdaq trading days.

The company made its original bid to acquire all outstanding shares of Illumina in cash on Jan. 27. Illumina's board unanimously rejected the offer in February, calling it "grossly inadequate," and has been urging its shareholders to vote against Roche's board nominees and board expansion plan.

Illumina issued a statement today after Roche extended its offer, saying, "Illumina is positioned to create far more value than Roche has offered. Our stockholders clearly agree."

In mid-morning trading today on the Nasdaq, shares of Illumina inched up 1 percent to $49.83.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.